by EmpathiCSubstanceS | Apr 8, 2020 | Anxiety
[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″...
by EmpathiCSubstanceS | Apr 8, 2020 | MDMA Sassafras Molly
[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression
Researching psychedelics to treat addiction Volunteers at some of the country’s leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit .. read from original article For most of...
by EmpathiCSubstanceS | Feb 8, 2020 | Anxiety
Following the popularity of ‘microdosing’ psychedelics to improve productivity, some are turning to these substances for career clarity. Paul Austin and Matt Gillespie are trying to retrace their steps along a path shrouded by redwood trees. All things...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression, Kambo
Marking an impressive milestone in the development of MDMA-assisted psychotherapy for PTSD, the U.S. Food and Drug Administration (FDA) has approved the treatment for Expanded Access, allowing certain patients access to the therapy before full market approval is...
